Page 323 - Read Online

Page 14 of 15 Hadadi et al. J Cancer Metastasis Treat 2018;4:25 I http://dx.doi.org/10.20517/2394-4722.2018.22

Financial support and sponsorship
The work was supported by funds from Evans-Allen Research program FY2017, USDA, Agricultural
Research Station, Virginia State University, Petersburg, Virginia. The financial support to Shrefa Hadadi was
provided by Saudi Arabian Culture Mission, Kingdom of Saudi Arabia.

Conflicts of interest
There are no conflicts of interest.

Patient consent
Not applicable.

Ethics approval
Animal or human tissues were not used; no ethical approval was required.

Copyright
© The Author(s) 2018.

REFERENCES
1. American Cancer Society. Cancer is the second most common cause of death in the United States, exceeded only by heart disease. In:
Cancer Facts & Figures 2006. Atlanta, GA: American Cancer Society; 2006.
2. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin 2017;67:7-30.
3. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and
mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.
4. Davidson NE, Armstrong SA, Coussens LM, Cruz-Correa MR, DeBerardinis RJ, Doroshow JH, Foti M, Hwu P, Kensler TW, Morrow M,
Mulligan CG, Pao W, Platz EA, Smith TJ, Willman CL. AACR Cancer Progress Report 2016. Clin Cancer Res 2016;22:S1-137.
5. Onitilo AA, Engel JM, Greenlee RT, Mukesh BN. Breast cancer subtypes based on ER/PR and Her2 expression: comparison of
clinicopathologic features and survival. Clin Med Res 2009;7:4-13.
6. Wagner AD, Thomssen C, Haertin J, Unverzagt S. Vascular-endothelial-growth-factor (VEGF) targeting therapies for endocrine refractory
or resistant metastatic breast cancer. Cochrane Database Syst Rev 2012;1:CD008941.
7. Jordan VC. Tamoxifen treatment for breast cancer: concept to gold standard. Oncology (Williston Park) 1997;11:7-13.
8. Ahmed S, James K, Owen CP, Patel CK, Patel M. Novel inhibitors of the enzyme estrone sulfatase (ES). Bioorg Med Chem Lett
2001;11:841-4.
9. Altundag K, Ibrahim NK. Aromatase inhibitors in breast cancer: an overview. Oncologist 2006;11:553-62.
10. Garrett JT, Rawale S, Allen SD, Phillips G, Forni G, Morris JC, Kaumaya PT. Novel engineered trastuzumab conformational epitopes
demonstrate in vitro and in vivo antitumour properties against HER-2/neu. J Immunol 2007;178:7120-31.
11. Lurje G, Lenz HJ. EGFR signaling and drug discovery. Oncology 2009;77:400-10.
12. Valabrega G, Montemurro F, Aglietta M. Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing
breast cancer. Ann Oncol 2007;18:977-84.
13. Dean-Colomb W, Esteva FJ. HER2-positive breast cancer: herceptin and beyond. Eur J Cancer 2008;44:2806-12.
14. Jain RK, Carmeliet PF. Vessels of death or life. Sci Am 2001;285:38-45.
15. Shih T, Lindley C. Bevacizumab: an angiogenesis inhibitor for the treatment of solid malignancies. Clin Ther 2006;28:1779-802.
16. Gotink KJ, Verheul HM. Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action? Angiogenesis 2010;13:1-14.
17. Farvid MS, Cho E, Chen WY, Eliassen AH, Willett WC. Dietary protein sources in early adulthood and breast cancer incidence: prospective
cohort study. BMJ 2014;348:g3437.
18. Kim MK, Kim JH, Nam SJ, Ryu S, Kong G. Dietary intake of soy protein and tofu in association with breast cancer risk based on a case-
control study. Nutr Cancer 2008;60:568-76.
19. Nechuta SJ, Caan BJ, Chen WY, Lu W, Chen Z, Kwan ML, Flatt SW, Zheng Y, Zheng W, Pierce JP. Soy food intake after diagnosis of
breast cancer and survival: an in-depth analysis of combined evidence from cohort studies of US and Chinese women. Am J Clin Nutr
2012;96:123-32.
20. Thomson CA, Rock CL, Thompson PA, Caan BJ, Cussler E, Flatt SW, Pierce JP. Vegetable intake is associated with reduced breast
cancer recurrence in tamoxifen users: a secondary analysis from the Women’s Healthy Eating and Living Study. Breast Cancer Res Treat
2011;125:519-27.
21. Lv ZD, Liu XP, Zhao WJ, Dong Q, Li FN, Wang HB, Kong B. Curcumin induces apoptosis in breast cancer cells and inhibits tumor growth
in vitro and in vivo. Int J Clin Exp Pathol 2014;7:2818-24.
22. Hu XJ, Xie MY, Kluxen FM, Diel P. Genistein modulates the anti-tumoractivity of cisplatin in MCF-7 breast and HT-29 colon cancer cells.
Arch Toxicol 2014;88:625-35.
23. Cai Q, Shu XO, Wen W, Cheng JR, Dai Q, Gao YT, Zheng W. Genetic polymorphism in the manganese superoxide dismutase gene,